The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 13, 2018

Filed:

Jul. 15, 2013
Applicant:

N.v. Nutricia, Zoetermeer, NL;

Inventor:

Robert Johan Joseph Hageman, Wageningen, NL;

Assignee:

N.V. Nutricia, Zoetermeer, NL;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/714 (2006.01); A61K 31/198 (2006.01); A61K 31/4188 (2006.01); A61K 36/48 (2006.01); A61K 36/81 (2006.01); A61K 36/899 (2006.01); A61K 38/01 (2006.01); A23L 13/60 (2016.01); A23L 23/10 (2016.01); A23L 33/17 (2016.01); A23L 33/175 (2016.01); A23L 33/18 (2016.01); A23L 33/185 (2016.01); A23L 33/19 (2016.01); A61K 38/02 (2006.01); A23L 33/00 (2016.01); A23L 13/40 (2016.01);
U.S. Cl.
CPC ...
A61K 31/714 (2013.01); A23L 13/424 (2016.08); A23L 13/65 (2016.08); A23L 23/10 (2016.08); A23L 33/17 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A23L 33/185 (2016.08); A23L 33/19 (2016.08); A23L 33/40 (2016.08); A61K 31/198 (2013.01); A61K 31/4188 (2013.01); A61K 36/48 (2013.01); A61K 36/81 (2013.01); A61K 36/899 (2013.01); A61K 38/01 (2013.01); A61K 38/02 (2013.01); A23V 2002/00 (2013.01);
Abstract

The invention relates to the use of specific protein and/or peptide fractions having a high aspartate content for regulating plasma glucose concentrations and increasing insulin sensitivity in a mammal. The invention relates to a complete food fortified with aspartate equivalents as well as a supplement rich in aspartate equivalents that is given simultaneously with or even minutes up to an hour prior to the consumption of a meal comprising glucose. The nutritional or pharmaceutical composition contains at least one protein having a high aspartate content, preferably of soy or dairy origin, which is further enriched with aspartate equivalents from another protein and/or free aspartate equivalents. The protein fraction comprises glutamate equivalents in a weight ratio of aspartate equivalents to glutamate equivalents (asp:glu) between 0.41:1 and 5:1.


Find Patent Forward Citations

Loading…